The silent killer presenting as pulmonary valve stenosis
| Autor: | Nicolas Nicolaou, Mark Andrew Nicolaou, Chris Conradie, Nigel Flint |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
business.industry Pulmonary disease Disease 030204 cardiovascular system & hematology medicine.disease Pulmonary hypertension 03 medical and health sciences PULMONARY EMBOLUS 0302 clinical medicine medicine.anatomical_structure Internal medicine Pulmonary valve Pulmonary valve stenosis medicine Cardiology Surgery business 030215 immunology |
| Zdroj: | International Journal of Surgery Open. 13:20-23 |
| ISSN: | 2405-8572 |
| DOI: | 10.1016/j.ijso.2018.07.006 |
| Popis: | Chronic Thrombo-Embolic Pulmonary Disease (CTEPD) is usually a silent disease representing a small group of patients who at some stage had suffered a thrombo-embolic event in which the individual may or may not have been aware of. It is estimated that this syndrome develops in approximately 3.8% of patients having suffered an acute Pulmonary Embolus (PE) thus representing a pool of patients estimated in the literature to be in the vicinity of 19,000 [1] It has further been documented that this condition is seriously underdiagnosed and is thought to represent in excess of 100,000 individuals in the United States with CTEPD which potentially could be "cured". |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|